PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.92%
Revenue growth of 5.92% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
5.52%
Gross profit growth of 5.52% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
29.29%
EBIT growth of 29.29% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
35.99%
Operating income growth of 35.99% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
30.23%
Net income growth of 30.23% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
30.21%
EPS growth exceeding 1.5x Healthcare median of 2.36%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
30.21%
Diluted EPS growth exceeding 1.5x Healthcare median of 2.22%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.27%
10Y CAGR of 57.27% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
-14.00%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
37.58%
3Y CAGR of 37.58% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
100.00%
OCF/share CAGR of 100.00% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
204.55%
Net income/share CAGR exceeding 1.5x Healthcare median of 9.00% over a decade. Joel Greenblatt might see a standout compounder of earnings.
1.06%
Below 50% of Healthcare median. Jim Chanos would suspect deeper problems limiting mid-term profit potential.
46.13%
3Y net income/share CAGR > 1.5x Healthcare median of 5.49%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
174.00%
Equity/share CAGR of 174.00% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
20.89%
5Y equity/share CAGR of 20.89% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
67.68%
3Y equity/share CAGR of 67.68% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.00%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
0.71%
Inventory growth of 0.71% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
0.86%
Asset growth of 0.86% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.21%
BV/share growth of 3.21% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
20.57%
Debt growth of 20.57% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-0.12%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.